Rafael Holdings, INC. (RFL) — 10-K Filings
All 10-K filings from Rafael Holdings, INC.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
Rafael Holdings Bets Big on Rare Disease Drug Amid Portfolio Shifts
— Oct 29, 2025 Risk: high
Rafael Holdings, Inc. (RFL) is a biotechnology company primarily focused on developing Trappsol Cyclo for Niemann-Pick Disease Type C1 (NPC1), a rare genetic di -
Rafael Holdings Files 2024 Annual Report
— Nov 7, 2024 Risk: low
Rafael Holdings, Inc. filed its annual report on Form 10-K for the fiscal year ended July 31, 2024. The company, incorporated in Delaware and headquartered in N
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX